Humanity 2.0 Lab, an alliance of health, academic, business and faith leaders, will develop gold standard for healthy maternal environments
NEW YORK, September 13, 2019 /3BL Media/ -- Humanity 2.0 Lab – the pioneering maternal health platform – published its first white paper on the state of maternal health worldwide. The paper identifies toxic environments as critical factors in hindering maternal health, including hundreds of women who die each day in pregnancy and childbirth, as well as impeding optimal health and development of the next generation.
April 11, 2019 /3BL Media/ Arrow Electronics and nonprofit We Care Solar won the 2019 Edison Award for Social Innovation for its joint development of Solar Suitcase 3.0, a portable and durable power system that provides sustainable energy for around-the-clock, effective obstetric care in remote and off-grid maternal health facilities around the world.
These two reproductive health advocates are part of a new generation of changemakers.
Amadi is one of 15 inspiring recipients of a small grant from Women Deliver, a global advocacy organization, and is part of a cohort of Women Deliver Young Leaders using technology provided by HP to improve access to comprehensive sexual and reproductive health education in Nigeria.
A black baby in the U.S. is more than twice as likely to die before its first birthday as a white baby. In addition to the medical care and access a woman and baby receive, these poor outcomes are also driven by social determinants of health—non-clinical factors such as social, educational, environmental, and economic opportunities that affect a woman’s overall health and wellbeing. This multi-faceted challenge requires a multi-faceted approach.
by Dr. Mary-Ann Etiebet, Executive Director of Merck for Mothers
Five years ago, Saving Mothers, Giving Life (SMGL) – a major public-private partnership – set the ambitious goal of reducing maternal mortality by half in target districts in Uganda and Zambia, and later Nigeria.
KENILWORTH, N.J., June 27, 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, through its Merck for Mothers initiative announced study results on an investigational heat-stable formulation of carbetocin for the prevention of excessive bleeding after childbirth, also known as postpartum haemorrhage (PPH).
by Dr. Neel Shah, Assistant Professor at Harvard Medical School
As an obstetrician, my job is to focus on moms and babies. But one of my favorite parts of childbirth is the look on a new dad’s face at the precise moment he sees his baby for the first time. The physical connection between moms and babies begins sooner and more gradually than it does for dads. Moms feel their babies growing and wriggling months before they get to actually see them. For dads, the first physical connection is visual. Fatherhood goes from being abstract to very real in an instant. And that look is everything.
At Merck for Mothers, we believe that actionable research is essential for taking on maternal mortality. On behalf of our team and many partners, we are pleased to share Evidence for Impact, our first Research Compendium. The publications included in this compendium advance our collective understanding of the problem of maternal mortality, inform the design and implementation of programs aiming to improve women’s health, and strengthen the global health community of practice to save women’s lives.
Merck for Mothers lead Dr. Naveen Rao has announced his intent to retire on July 1. Dr. Rao has led Merck for Mothers since its inception, and was responsible for leveraging Merck's scientific and business expertise to accelerate the program's progress. Dr. Mary-Ann Etiebet, currently the executive director, will succeed Dr. Rao.
May 24, 2018 /3BL Media/ - Merck for Mothers lead Dr. Naveen Rao has announced his intent to retire, effective July 1. Dr. Rao initiated and led Merck for Mothers, Merck’s 10-year, $500 million initiative to reduce maternal mortality around the world. He was responsible for leveraging the company’s science and business expertise to accelerate progress in reaching the Sustainable Development Goals and advancing Merck’s mission to improve and save lives.